IPP Bureau
FDA nod to priority review to AstraZeneca’s Baxdrostat for hard-to-control hypertension
By IPP Bureau - December 04, 2025
Here's a development that aims to keep your blood pressure in check. Literally!
Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis
By IPP Bureau - December 04, 2025
The company is excluding data from the affected sites to maintain the study's integrity
Promotion of indigenous pharmaceutical manufacturing
By IPP Bureau - December 04, 2025
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Avandra Health acquires DatCard and Sorna to build industry-leading medical imaging platform
By IPP Bureau - December 03, 2025
The acquisitions merge DatCard and Sorna’s expertise in clinical data sharing with Avandra’s de-identified patient data aggregation platform
Imugene reports strong early results for Azer-cel in aggressive blood cancer trial
By IPP Bureau - December 03, 2025
Celltrion gets Health Canada nod for Eylea biosimilar Eydenzelt
By IPP Bureau - December 03, 2025
Health Canada’s approval was based on a comprehensive evaluation of analytical, nonclinical, and clinical data
EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
By IPP Bureau - December 03, 2025
Angelini Ventures has already invested €125 million in 22 startups
L&T Technology unveils next-gen AI digital twin for lung diagnostics
By IPP Bureau - December 03, 2025
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
Citius Oncology's new therapy offers new hope for cutaneous T-cell lymphoma patients
By IPP Bureau - December 03, 2025
LYMPHIR addresses a clear clinical need in a disease with limited treatment options
Merck unveils first human data for Alzheimer’s candidates
By IPP Bureau - December 03, 2025
The company also revealed that MK-2214 has received Fast Track Designation from the U.S. Food and Drug Administration
Sound's for hearing loss: Co's drug wins FDA breakthrough tag for Meniere’s disease
By IPP Bureau - December 03, 2025
Here's a new ray of hope for new hope for patients suffering from Meniere’s disease (MD) and sensorineural hearing loss
Biocon Biologics secures market entry date for Denosumab biosimilars in Europe, Rest of the World
By IPP Bureau - December 03, 2025
The agreement allows Biocon Biologics to commercialize both its Denosumab biosimilars (Vevzuo and Evfraxy) in Europe starting December 2, 2025
US District Court grants summary judgement in Favour of SPARC for Sezaby PRV
By IPP Bureau - December 03, 2025
FDA's withholding of the PRV was contrary to law because no drug product containing phenobarbital sodium was 'previously approved'
US & UK reach historic pharma pricing pact
By IPP Bureau - December 03, 2025
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
AbbVie’s Atogepant shows breakthrough results for acute migraine relief
By IPP Bureau - December 03, 2025
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
